This company has been marked as potentially delisted and may not be actively trading. XORTX Therapeutics (XRTX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesShort InterestTrendsBuy This Stock XRTX vs. NEUP, ME, EDSA, BCTX, LIPO, NERV, EQ, AYTU, AIMD, and BTAIShould you be buying XORTX Therapeutics stock or one of its competitors? The main competitors of XORTX Therapeutics include Neuphoria Therapeutics Inc. - Common Stock (NEUP), 23andMe (ME), Edesa Biotech (EDSA), BriaCell Therapeutics (BCTX), Lipella Pharmaceuticals (LIPO), Minerva Neurosciences (NERV), Equillium (EQ), Aytu BioPharma (AYTU), Ainos (AIMD), and BioXcel Therapeutics (BTAI). These companies are all part of the "medical" sector. XORTX Therapeutics vs. Its Competitors Neuphoria Therapeutics Inc. - Common Stock 23andMe Edesa Biotech BriaCell Therapeutics Lipella Pharmaceuticals Minerva Neurosciences Equillium Aytu BioPharma Ainos BioXcel Therapeutics Neuphoria Therapeutics (NASDAQ:NEUP) and XORTX Therapeutics (NASDAQ:XRTX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, community ranking, profitability and institutional ownership. Is NEUP or XRTX more profitable? Neuphoria Therapeutics' return on equity of 0.00% beat XORTX Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Neuphoria TherapeuticsN/A N/A N/A XORTX Therapeutics N/A -36.38%-24.45% Do analysts prefer NEUP or XRTX? Neuphoria Therapeutics currently has a consensus price target of $21.00, indicating a potential upside of 208.82%. Given Neuphoria Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Neuphoria Therapeutics is more favorable than XORTX Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neuphoria Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00XORTX Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals have more ownership in NEUP or XRTX? 15.9% of Neuphoria Therapeutics shares are held by institutional investors. Comparatively, 0.2% of XORTX Therapeutics shares are held by institutional investors. 0.7% of Neuphoria Therapeutics shares are held by insiders. Comparatively, 6.9% of XORTX Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more risk and volatility, NEUP or XRTX? Neuphoria Therapeutics has a beta of 0.46, suggesting that its share price is 54% less volatile than the S&P 500. Comparatively, XORTX Therapeutics has a beta of 0.52, suggesting that its share price is 48% less volatile than the S&P 500. Which has higher valuation & earnings, NEUP or XRTX? XORTX Therapeutics has lower revenue, but higher earnings than Neuphoria Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuphoria Therapeutics$10K1,278.40-$15.49MN/AN/AXORTX TherapeuticsN/AN/A-$3.31M-$1.35-0.65 Does the MarketBeat Community believe in NEUP or XRTX? XORTX Therapeutics received 155 more outperform votes than Neuphoria Therapeutics when rated by MarketBeat users. However, 100.00% of users gave Neuphoria Therapeutics an outperform vote while only 63.41% of users gave XORTX Therapeutics an outperform vote. CompanyUnderperformOutperformNeuphoria TherapeuticsOutperform Votes1100.00% Underperform VotesNo VotesXORTX TherapeuticsOutperform Votes15663.41% Underperform Votes9036.59% Does the media prefer NEUP or XRTX? In the previous week, Neuphoria Therapeutics' average media sentiment score of 0.00 equaled XORTX Therapeutics'average media sentiment score. Company Overall Sentiment Neuphoria Therapeutics Neutral XORTX Therapeutics Neutral SummaryNeuphoria Therapeutics beats XORTX Therapeutics on 8 of the 12 factors compared between the two stocks. Get XORTX Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for XRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XRTX vs. The Competition Export to ExcelMetricXORTX TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.31M$2.38B$5.21B$8.59BDividend YieldN/A1.56%5.36%4.20%P/E Ratio-3.018.7925.7519.16Price / SalesN/A495.16395.62100.86Price / CashN/A150.4135.5255.99Price / Book0.995.287.985.79Net Income-$3.31M$31.14M$3.15B$248.88M XORTX Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XRTXXORTX TherapeuticsN/A$0.87+1.5%N/A-58.3%$3.31MN/A-3.01N/AShort Interest ↑NEUPNeuphoria Therapeutics Inc. - Common StockN/A$7.18+5.3%$21.00+192.5%N/A$13.50M$15.66M0.00N/AME23andMeN/A$0.50-35.3%N/A-94.0%$13.36M$208.78M-0.03770Gap DownHigh Trading VolumeEDSAEdesa Biotech3.1157 of 5 stars$1.90-3.1%$21.00+1,005.3%-54.0%$13.34MN/A-1.0220Gap UpBCTXBriaCell Therapeutics2.5133 of 5 stars$3.47-0.3%$32.00+822.2%-84.3%$12.87MN/A-0.268Positive NewsEarnings ReportLIPOLipella Pharmaceuticals1.4792 of 5 stars$2.88-1.0%N/A-68.0%$12.87M$536.36K-0.684News CoverageGap DownNERVMinerva Neurosciences3.4575 of 5 stars$1.80-2.2%$5.00+177.8%-47.8%$12.59MN/A-4.099News CoverageEQEquillium2.4552 of 5 stars$0.35-7.7%$3.00+755.7%-50.8%$12.52M$30.41M-2.5040AYTUAytu BioPharma1.2869 of 5 stars$2.02-4.3%N/A-28.1%$12.46M$81.66M-1.39160AIMDAinos0.6379 of 5 stars$0.59-4.3%N/A-41.7%$12.29M$106.21K-0.4640Gap DownBTAIBioXcel Therapeutics3.5187 of 5 stars$1.99+1.5%$42.60+2,040.7%-91.2%$12.05M$1.85M-0.0690Gap Up Related Companies and Tools Related Companies NEUP Alternatives ME Alternatives EDSA Alternatives BCTX Alternatives LIPO Alternatives NERV Alternatives EQ Alternatives AYTU Alternatives AIMD Alternatives BTAI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XRTX) was last updated on 6/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XORTX Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share XORTX Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XRTX Stock Free XRTX Stock Alerts